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Abstract 
 Synthesis of 1,4-bis(oxazoline) ligands bearing a bicyclo[2,2,2]backbone derived from 
9,10-dihydro-9,10-ethanoanthacene trans-dicarboxylic acid was revisited. Starting from L- or 
D-amino alcohols and either (S,S) or (R,R)-dihydroethano trans-dicarboxylic acid, a complete 
series of ligands was evaluated in the copper-catalyzed Diels-Alder reaction. The most 
efficient ligands with a phenyl substituent on the oxazoline ring afforded enantiomeric excess 
up to 98%. This is different from previous results indicating that the best enantioselectivity 
involved a diastereomeric ligand with the meso-backbone. 
 
Keywords: Chiral bis(oxazoline) synthesis; Bicyclo[2.2.2] backbone; Diels-Alder catalysis; 
Copper; Enantioselectivity. 
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1. Introduction 
Chiral bis(oxazoline) ligands have emerged as one class of important and efficient C2-
symmetric ligands in numerous metal-catalyzed asymmetric transformations.1-9 Among them, 
a novel class of oxazoline ligands with multiple elements of chirality has been synthesized 
from readily available chiral diacid and chiral amino alcohol (Fig. 1). Besides the central 
chirality element in the oxazoline moiety, these ligands possess an additional chirality element 
in the backbone such as 1,3-dioxolane I,10-12 bicyclo [2,2,1] II, [2,2,2] III,13 cyclohexane 
IV,14,15 and cyclopentane V.16  
 
Fig. 1.  
Although the Diels-Alder reaction between acrylimide dienophiles and 
cyclopentadiene was the most successful application of the Cu(II)-bis(oxazoline) catalytic 
system with enantiomeric excess up to 99%,17-31 its application with the ligands I, II, III, IV 
and V was less effective in enantioselectivity. In particular, the ligand III, previously 
introduced by Takacs et al.,13 has particularly focused our attention since the best 
enantioselectivity (75%) in the Diels-Alder reaction surprisingly involves the meso-backbone 
and poor results were obtained with the other chiral configurations. Moreover, the authors13 
indicated that a phenomenon of epimerization was observed during the synthesis of these 
ligands. These results inspired us to reinvestigate the synthesis of these ligands with more 
convenient routes to better control the stability of their relative configuration. 
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In the present work we revisit this class of bis(oxazoline) ligands in which the two 
oxazolines are separated by a dihydroethanoanthracene backbone (Figure 1, III). With the 
goal to rationalize and optimize the results obtained in catalysis, a more convenient 
preparation of the ligand was first described and the four diastereomers were preparated in 
pure form. The effect of structure change of the ligands on the stereochemical outcome of the 
asymmetric copper-catalyzed Diels-Alder reaction between N-acryloyloxazolidinone or N-
crotonyloxazolidinone and cyclopentadiene was then fully investigated yielding high 
enantiomeric excess (up to 98%). As expected, the best ees were obtained with pure R,R and 
S,S bis(oxazoline), provided that the chirality of the backbone matched correctly the chirality 
of the bis(oxazoline). 
 
2. Results and Discussion 
The bis(oxazoline) ligands were synthesized from the corresponding 9,10-dihydro-
9,10-ethanoanthacene trans-(11S,12S) and trans-(11R,12R) dicarboxylic acid (1) as shown in 
Scheme 1. After chiral separation with brucine,32 conversion of the diacid into the 
corresponding acid dichloride by reaction with the oxalyl chloride16 was accomplished within 
1 h. After removing the solvent and excess oxalyl chloride, the product was used in the next 
step without purification. Overnight reaction with 2.2 equiv of the amino alcohol in the 
presence of triethylamine afforded the expected bis-hydroxyamide 3 as a white solid in 60-
85% yield. The 1H NMR analysis confirmed the presence of the desired product as a single 
diastereomer. It should be noted that some epimerization occurs with the previously requisited 
procedure13 in forming the diamide intermediate. 
Conversion of bis(hydroxyamide) 3 to the corresponding bis(oxazoline) 4 was carried 
out in one step by reaction with diethylaminosulfur trifluoride in CH2Cl2 at -78°C followed by 
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base induced cyclisation16,9 in 50-80% yield. For the ligand 4d, the bis(hydroxyamide) 3d was 
first converted into the bis(amide) dichloride with SOCl2 and then the cyclization was 
achieved with aqueous NaOH in 73% yield. The dihydroxyamide 6 with the meso-backbone 
was synthesized from the anhydride 5 (not the acid)33 and the (R)-phenylglycinol in the 
presence of the coupling reagent N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) 
in 77% yield.34,16 
The corresponding meso-bis(oxazoline) ligand 7 was prepared using a similar route 
with diethylaminosulfur trifluoride in CH2Cl2 at -78°C. After purification on column 
chromatography, the 1H NMR spectrum shows peaks corresponding to ligands 4a and 
4e'(15%) due to epimerization (Fig. 2(A)).The 1H NMR analysis confirms the progressive 
disappearance of 7 after 24h (50%, Fig. 2(B)) and after 48 hours, there is total conversion into 
the ligands 4a and 4e' in a ratio 53/47 (Fig. 2(C)). 
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Scheme 1.  
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Fig. 2 
 
 An X-ray structure of the bis(oxazoline) ligand 4a has been solved (Fig. 3).35 X-ray 
diffraction analysis shows that the two chiral oxazoline rings are slightly twisted pushing the 
two oxazolinyl phenyl towards the metal centre. In contrast, X-ray structure of the other 
diastereomer ligand 4e' (using the (R)-phenyl glycinol and trans-(11R,12R)-dicarboxylic acid 
1),13 showed that the two oxazolinyl phenyl are far away from the metal centre in the 
complex.  
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Fig. 3. 
 The Diels-Alder reaction of N-acryloyloxazolidinone 8a or N-crotonyloxazolidinone 
8b19 and cyclopentadiene in the presence of various chiral catalysts derived from the ligands 4 
and Cu(II) triflate was then investigated. The catalytic results are summarized in Table 1.  
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Table 1.  
Diels-Alder reaction of 8 with cyclopentadiene catalyzed by Cu(II)(OTf)2/bis(oxazoline) 
complexesa 
 
Entry Ligand 
 
Time (min) Temp (°C) Yieldb (%) endo/exoc(%) 
 
eeendo
d
 (%) (config.) 
 
1 4a 5 20 95 94/6 93 (R) 
2 4a’ 10 20 80 75/25 21 (R) 
3 4b 30 20 80 85/15 16 (R) 
4 4c 240 20 50 88/12 10 (S) 
5 4d 10 20 80 88/12 20 (R) 
6 4e 5 20 95 94/6 94 (S) 
7 4e' 15 20 82 76/24 22 (S) 
8 4fe 10 20 80 90/10 76 (R) 
9 7 5 20 82 88/12 77 (R) 
10f 4af 240 20 85 93/7 89 (R) 
11 4a 5 0 95 96/4 95 (R) 
12 4a 30 -40 93 98/2 98 (R) 
13 4e 5 0 95 96/4 96 (S) 
14 4e 45 -40 92 98/2 98 (S) 
aMolar ratio of metal/ligand/diene/dienophile: 1/1.2/150/50. 
 
bIsolated yield of cycloadducts after silica gel chromatography.  
cDetermined by 1H NMR and HPLC.  
dDetermined by chiral HPLC (Chiralcel OD-H column) and comparison of known optical rotation.  
eLigand prepared from the racemic trans-dicarboxylic acid 1 and (-)-(R)- phenylglycinol.  
fN-crotonyloxazolidinone as dienophile. 
 From the results of Table 1, it is shown that the ligands 4a and 4e with the phenyl 
substituted oxazoline gave the best ee (93-94%) and endo/exo diastereoselectivity (94/6) 
(entries 1 and 6). With the ligand 4a' or 4e', in which the chirality of the oxazoline ring has 
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been inverted, the ee was decreased (21%), as well as the diastereoselectivity (75/25) (entries 
2 and 7). The ligands with i-Pr 4b and t-Bu 4c gave low ee (< 20%) (entries 3 and 4). The 
high reactivity of the catalyst leads to short reaction times (5-10mn) with yields in the range 
80-95%, excepted for the bulky t-Bu group (50% yield) in which a longer reaction time was 
necessary (4 hours). We also decided to test N-crotonyloxazolidinone 8b as a substrate to 
compare our results with those previously reported.13 In our hands, the endo-cycloadduct 9 
was obtained with 89% ee and R configuration, using 4a as ligand (entry 10), whereas it was 
previously reported13 an enantiomeric excess of 28% with S configuration in a similar 
situation. 
The effect of temperature was studied with ligands 4a and 4e. The highest ee and 
diastereoselectivity was obtained at -40°C (98% and 98/2 respectively) (entries 12 and 14).  
The influence of substitution both on the oxazoline ring and on the backbone moiety 
has been investigated with the goal of better understanding the stereocontrol of the Cu(II)-
catalyzed reaction. According to the structure (Fig. 3), we have prepared and tested the four 
diastereomeric ligands 4 with the phenyl group on the oxazoline ring (as represented in Fig. 
4). By changing combination of the enantiomers derived from (+) or (-)-trans-dicarboxylic 
acid and aminoalcohol, the stereochemistry of the four asymmetric centres can be adjustable. 
There are two sets of enantiomer pairs corresponding to the ligands 4a, 4e and 4a', 4e'. The 
two phenyl groups on the oxazoline ring of ligand 4a and 4e are placed nearer to the reaction 
centre than those of 4a' and 4e', and consequently, have a larger effect on the 
enantioselectivity (93% versus 21%). These results show that the degree of asymmetric 
induction depends of the chirality on the oxazoline ring in 4a and 4a’ or 4e and 4e'. 
Furthermore, with the ligands 4a and 4a’ or 4e and 4e', the same endo-9(R) or 9(S) -
cycloadduct was obtained. The sense of asymmetric induction was logically inverted with the 
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enantiomeric ligands 4a and 4e or 4a’ and 4e' but also with the ligands 4a and 4e' or 4a’ and 
4e. These results demonstrate that the chiral sense of enantioselection was determined by the 
chirality of the backbone. To complete the study, it was also noted that ligand 4d with no 
substituent on the oxazoline ring gave an enantioselectivity of 20% (entry 5). This value was 
similar to the enantioselectivity obtained with ligand 4a' (entry 2). 
In our hands, the ligand 7 gave an ee = 77% for endo-9 (R)-cycloadduct (entry 9). 
Actually, this value is very close to that obtained with the ligand 4f derived from the racemic 
trans-dicarboxylic acid 1 and (-)-(R)-phenylglycinol, ee = 76% endo-9(R)-cycloadduct (entry 
8). Taking into account the epimerization observed in the NMR study, an epimerization of the 
ligand 7 may also occur in the catalytic conditions. Since the epimerization is time dependent, 
a study of the ee obtained using ligand 7 over the time course of the catalytic reaction might 
be necessary. However, the short time of the catalytic reaction (<5 min) makes this study too 
difficult. It should be noted that previous results13 gave an ee of 75% for endo-9(R)-
cycloadduct, quite similar to our results (77% ee).  
 
 
Fig. 4.  
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3. Conclusion 
In conclusion, the synthesis of bis(oxazoline) ligands with four asymmetric centres by 
combination of the two chiral sources derived from the dihydroethanoanthracene diacid and 
aminoacids are revisited, and well-structured chiral ligands have been isolated and 
characterized. The copper-catalyzed asymmetric Diels-Alder reaction between N-
acryloyloxazolidinone and N-crotonyloxazolidinone with cyclopentadiene was carried out 
with these chiral ligands. The best adapted combination for the ligands 4a and 4e gave ees up 
to 98% at -40°C. Studies on the potential of these ligands for other metal-catalyzed 
asymmetric reactions are now in progress. 
4. Experimental  
4.1. General 
All reactions were performed under argon. Solvent was distilled from appropriate drying 
agent, CH2Cl2 from CaH2. Commercially available reagents were used without further 
purification unless otherwise stated. All reactions were monitored by TLC with Merck 
precoated aluminium foil sheets (silica gel 60 with fluorescent indicator UV254). Column 
chromatographies were carried out using silica gel from Acros (0.063-0.200 mm). Melting 
points were measured on a banc Kofler. 1H NMR and 13C NMR in CDCl3 were recorded 
using Bruker (Advance 400dpx) spectrometer at 400 and 100 MHz respectively.The 
following abbreviations are used in connexion with NMR; s=singlet, d=doublet, t=triplet, 
q=quartet and m=multiplet. Chiral HPLC analysis  was performed on a Varian Prostar 218 
system equipped with a Chiralcel OD-H column. Optical rotations were recorded with a 
Perkin-Elmer 341 polarimeter. High resolution mass spectra were performed by the Centre 
Regional de Mesures Physiques de l’Ouest (CRMPO) at Rennes, France, on a Q-Tof2 
spectrometer in ESI positif mode. 
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4.2. General procedure of preparation of bis-hydroxyamides 3a, 3a’, 3b, 3c, 3d, 3e, 3e', 
3f and 6 
Oxalyl chloride (3 equiv) was added dropwise to a cooled suspension (0°C) of the trans- 
diacide (-)-1 or (+)-1 and dimethylformamide (15 mol %) in CH2Cl2 (5 mL/mmol) under 
argon. The reaction mixture was stirred at room temperature for 2 h to give a yellow solution 
of the trans-diacide chloride (-)-2 or (+)-2. The solvent and excess oxalyl chloride were 
removed in high vacuum, the residue was taken up in CH2Cl2 (4 mL/mmol) and added slowly 
to a cold solution (0°C) of the corresponding amino alcohol (2.2 equiv) and Et3N (5 equiv) in 
CH2Cl2 (2 mL/mmol) under argon. Stirring was continued for 16 h at room temperature. After 
evaporation, the crude product was purified by column chromatography (Hexane-EtOAc-
MeOH).  
4.2.1. (11S,12S)-Bis[(2’-hydroxy-1’-(R)-phenylethyl)]-amido-9,10-dihydro-9,10-
ethanoanthacene 3a 
The product was synthesized according to the general procedure described above from 9,10-
dihydro-9,10-ethanoanthacene trans-(11S,12S)-dicarboxylic acid 1 (0.5 g,1.7 mmol) and (-)-
(R)- phenylglycinol (0.65 g, 3.74 mmol). Purification by column chromatography (hexane-
EtOAc, 1:9) yielded a white solid (840 mg, 93%): m.p.= 147-148 °C; []D20 = -34 (c 1.44, 
CHCl3); 1H NMR (400 MHz , CDCl3):  = 2.91 (s, 2H), 3.66 (br s, 4H), 4.59 (s, 2H), 4.90 (br 
s, 2H), 7.06-7.32 (m, 18H); 13C NMR (100 MHz, CDCl3):  = 46.8, 49.6, 55.8, 66.07, 123.4, 
125.4, 126.3, 126.7, 127.6, 128.6, 138.8, 140.1, 143.0, 173.5; HRMS [ESI]: m/z calcd for 
C34H32N2O4Na: 555.2259 (M+Na)+, found: 555.2255. 
4.2.2. (11S,12S)-Bis[(2’-hydroxy-1’-(S)-phenylethyl)]-amido-9,10-dihydro-9,10-
ethanoanthacene 3a'  
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The product was synthesized according to the general procedure described above from 9,10-
dihydro-9,10-ethanoanthacene trans-(11S,12S)-dicarboxylic acid 1 (0.5 g,1.7 mmol) and (+)-
(S)- phenylglycinol (0.65 g, 3.74 mmol). Purification by column chromatography (EtOAc-
MeOH , 0:1) yielded a white solid (720 mg, 80%): m.p.= 174 °C: []D20 = +32 (c 0.84, 
CHCl3); 1H NMR (400 MHz , CDCl3):  = 2.96 (s, 2H), 3.68 (dd, J = 6.4, 11.6 Hz, 2H), 3.73 
(dd, J = 3.6, 11.4 Hz, 2H), 4.59 (s, 2H), 4.90 (dd, J = 7.2, 11.2 Hz, 2H), 7.00-7.04 (m, 6H), 
7.16-7.22 (m, 8H), 7.28, 7.58 (2d, J = 8 Hz, 4H); 13C NMR (100 MHz, CDCl3):  = 45.9, 
48.9, 56.2, 65.6, 123.4, 125.3, 125.9, 126.7, 127.3, 128.4, 139.6, 140.4, 143.3, 173.5; HRMS 
[ESI]: m/z calcd for C34H32N2O4Na: 555.2259 (M+Na)+, found: 555.2255.  
4.2.3. (11S,12S)-Bis[(2’-hydroxy-1’-(S)-isopropylethyl)]-amido-9,10-dihydro-9,10-
ethanoanthacene 3b 
The product was synthesized according to the general procedure described above from 9,10-
dihydro-9,10-ethanoanthacene trans-(11S,12S)-dicarboxylic acid 1 (0.5 g,1.7 mmol) and (+)-
L-Leucinol (0.438 g, 3.74 mmol). Purification by column chromatography (hexane-EtOAc, 
9:1) yielded a white solid (635 mg, 80%): m.p.= 134-135 °C; []D20 = -18 (c 0.55 , CHCl3); 
1H NMR (400 MHz , CDCl3):  = 0.78, 0.80 (2d, J = 6.4 Hz, 12H), 1.09-1.16, 1.22-1.29 (2m, 
4H), 1.39-1.47 (m, 2H), 2.88 (s, 2H), 3.23 (dd, J = 6.8, 11.4 Hz, 2H), 3.46 (dd, J = 3.6, 11.6 
Hz, 2H), 3.85 (br s, 2H), 4.46 (s, 2H), 7.00-7.06 (m, 4H), 7.21, 7.24 (2d, J = 6.8 Hz, 4H); 13C 
NMR (100 MHz, CDCl3):  = 22.0, 23.2, 24.8, 40.2, 46.9, 49.6, 65.4, , 123.2, 125.4, 126.21, 
140.3, 143.2, 173.8; HRMS [ESI]: m/z calcd for C30H40N2O4Na: 515.2885 (M+Na)+, found: 
515.2883. 
4.2.4. (11S,12S)-Bis[(2’-hydroxy-1’-(S)-tert-butylethyl)]-amido-9,10-dihydro-9,10-
ethanoanthacene 3c 
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The product was synthesized according to the general procedure described above from 9,10-
dihydro-9,10-ethanoanthacene trans-(11S,12S)-dicarboxylic acid 1 (1.0 g, 3.4 mmol) and (+)-
(S)-tert-Leucinol (0.876 g, 7.48 mmol). Purification by column chromatography 
(EtOAc:MeOH, 4:1) yielded a white solid (1.27 g, 77%): m.p.= 220 °C; []36520 = +57 (c 0.95 
, CHCl3); 1H NMR (400 MHz , CDCl3):  = 2.90 (s, 2H), 2.92 (t, J = 6.8 Hz, 2H), 3.36-3.43 
(m, 2H), 3.73-3.79 (m, 4H), 4.62 (s, 2H), 7.10-7.17 (m, 4H), 7.28, 7.42 (2d, J = 6.4 Hz, 4H); 
13C NMR (100 MHz, CDCl3):  = 26.8, 33.5, 46.3, 50.5, 59.6, 62.4, , 123.2, 125.7, 126.3, 
126.4, 140.2, 143.4, 174.7; HRMS [ESI]: m/z calcd for C30H40N2O4Na: 515.2885 (M+Na)+, 
found: 515.2887. 
4.2.5. (11S,12S)-Bis[(2’-hydroxy-ethyl)]-amido-9,10-dihydro-9,10-ethanoanthacene 3d 
The product was synthesized according to the general procedure described above from 9,10-
dihydro-9,10-ethanoanthacene trans-(11S,12S)-dicarboxylic acid 1 (1 g, 3.40 mmol),  and 
ethanolamine (0.457 g, 7.48 mmol) in THF (5 ml/mmol). Recrystallization from methanol 
yielded a white solid (578 mg, 45%): m.p.= 262 °C; []D20 = +40 (c 2.25, CH3OH); 1H NMR 
(400 MHz , CD3OD):  = 3.28-3.33 (m, 6H), 3.56 (t, J = 6 Hz, 4H), 4.60 (s, 2H), 7.09 
(quintuplet, J = 7.2 Hz, 4H), 7.24 (d, J = 6.8 Hz, 2H), 7.35 (d, J = 6.4 Hz, 2H); 13C NMR (100 
MHz, CD3OD):  = 40.9, 46.5, 59.7, 122.0, 123.8, 124.9, 139.1, 141.7, 172.6; HRMS [ESI]: 
m/z calcd for C22H24N2O4Na: 403.1633 (M+Na)+, found: 403.1633. 
4.2.6. (11R,12R)-Bis[(2’-hydroxy-1’-(S)-phenylethyl)]-amido-9,10-dihydro-9,10-
ethanoanthacene 3e 
The product was synthesized according to the general procedure described above from 9,10-
dihydro-9,10-ethanoanthacene trans-(11R,12R)-dicarboxylic acid 1 (0.5 g,1.7 mmol) and (+)-
(S)- phenylglycinol (0.65 g, 3.74 mmol). Purification by column chromatography (hexane-
EtOAc, 1:9) yielded a white solid (820 mg, 91%): m.p.= 137-138 °C; []D20 = +30 (c 0.51, 
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CHCl3); 1H NMR (400 MHz , CDCl3):  = 2.92 (s, 2H), 3.64 (m, 4H), 4.58 (s, 2H), 4.89 (dd, 
J = 5.0, 11.8 Hz, 2H), 7.04-7.30 (m, 18H); 13C NMR (100 MHz, CDCl3):  = 46.1, 50.1, 55.8, 
66.7, 123.5, 125.5, 126.5, 126.6, 127.8, 128.8, 138.5, 140.0, 143.0, 173.6; HRMS [ESI]: m/z 
calcd for C34H32N2O4Na: 555.2259 (M+Na)+, found: 555.2255. 
4.2.7. (11R,12R)-Bis[(2’-hydroxy-1’-(R)-phenylethyl)]-amido-9,10-dihydro-9,10-
ethanoanthacene 3e' 
The product was synthesized according to the general procedure described above from 9,10-
dihydro-9,10-ethanoanthacene trans-(11R,12R)-dicarboxylic acid 1 (0.5 g,1.7 mmol) and (-)-
(R)- phenylglycinol (0.65 g, 3.74 mmol). A white precipitate was formed in the solution  and 
it was filtered, washed with CH2CL2 and dried in vacuum to provide the corresponding 
bis(hydroxyamide) (768 mg, 85%): m.p.= 148-150°C; []D20 = -31 (c 0.71, CHCl3); 1H NMR 
(400 MHz , CDCl3):  = 3.19 (s, 2H), 3.75 (br s, 4H), 4.69 (s, 2H), 4.95 (br d, 2H), 7.02 (dd, J 
= 4.0, 8.4 Hz, 2H), 7.19-7.31 (m, 14H), 7.90 (d, J = 7.2 Hz, 2H); 13C NMR (100 MHz, 
CDCl3):  = 46.7, 49.3, 56.1, 65.7, 123.4, 125.4, 126.0, 126.0, 126.7, 128.5, 139.4, 140.4, 
143.3, 173.5; HRMS [ESI]: m/z calcd for C34H32N2O4Na: 555.2259 (M+Na)+, found: 
555.2255. 
4.2.8. (11S,12S+11R,12R)-Bis[(2’-hydroxy-1’-(R)-phenylethyl)]-amido-9,10-dihydro-
9,10-ethanoanthacene 3f 
The product was synthesized according to the general procedure described above from 
racemic- 9,10-dihydro-9,10-ethanoanthacene trans-dicarboxylic acid 1 (0.5 g,1.7 mmol) and 
(-)-(R)- phenylglycinol (0.65 g, 3.74 mmol). Purification by column chromatography 
(EtOAc), yielded a white solid (690 mg, 76%): m.p.= 150 °C; []58920 = -33 (c 1.94, CHCl3); 
1H NMR (400 MHz , CDCl3):  = 3.08 (s, 2H), 3.66 (br s, 4H), 4.60 (s, 2H), 4.87 (br s, 2H), 
6.93-7.22 (m, 16H), 7.77 (d, J = 7.2 Hz, 2H); 13C NMR (100 MHz, CDCl3):  = 45.9, 49.3, 
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56.1, 65.8, 123.4, 125.4, 126.0, 126.7, 127.4, 128.5, 139.4, 140.4, 143.3, 173.58; HRMS 
[ESI]: m/z calcd for C34H32N2O4Na: 555.2259 (M+Na)+, found: 555.2255 
4.2.9. Bis[(2’-hydroxy-1’-(R)-phenylethyl)]-amido-9,10-dihydro-9,10-ethanoanthacene 6 
The product was synthesized from the cis-9,10-dihydro-9,10-ethanoanthacene dicarboxylic 
anhydride 5 (225mg, 0.9 mmol), (-)-(R)- phenylglycinol (156mg, 0.9 mmol) and N-
Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (247 mg, 1.0 mmol) in 10 ml of THF at 
ambiante temperature for 48 h. Purification by column chromatography (EtOAc-MeOH , 9:1) 
yielded a white solid (185 mg, 77%): m.p.= 125-127 °C; []58920 = -73 (c 0.82 , CHCl3); 1H 
NMR (400 MHz , CDCl3):  = 3.12 (dd, J = 12.0, 22.8 Hz, 2H), 3.23, 3.26 (2d, J = 6.8 Hz, 
1H), 3.57-3.63 (m 2H), 3.73, 3.75 (2d, J = 3.6 Hz, 1H), 4.040 (dd, J = 7.2,14.4 Hz, 1H), 4.41 
(br s, 1H), 4.80 (m, 1H), 4.90 (m, 1H), 7.02-7.36 (m, 18H); 13C NMR (100 MHz, CDCl3):  = 
46.2, 47.0, 49.4, 50.6, 55.5, 56.2, 65.2, 65.6 123.5, 123.6, 124.5, 126.3, 126.4, 126.9, 127.0, 
127.1, 127.2, 127.7, 127.8, 128.7, 128.7, 138.8, 139.3, 139.5, 141.9, 142.4, 142.8, 172.4, 
173.1; HRMS [ESI]: m/z calcd for C34H32N2O4Na: 555.22598 (M+Na)+, found: 555.2257. 
 
4.3. General procedure of preparation of bis(oxazoline) 4a, 4a’, 4b, 4c, 4d, 4e, 4e', 4f, and 
7 
Diethylaminosulfur trifluoride (2.2 equiv) was added dropwise to a cooled  suspension (-
78°C) of the corresponding bis-hydroxyamide in dry CH2Cl2 (10 mL/mmol) under argon. 
After stirring for 3-5 h at the indicated temperature, anhydrous K2CO3 (3 equiv) was added 
and the reaction mixture was allowed to warm to room temperature. A saturated aqueous 
NaHCO3 solution was added and after phase separation the aqueous layer was extracted with 
CH2Cl2. After drying over MgSO4 and evaporation, the crude product was purified by column 
chromatography (Hexane-EtOAc).  
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4.3.1. (11S,12S)-Bis[(4’R)-phenyloxazoline]-9,10-dihydro-9,10-ethanoanthacene 4a 
The product was synthesized from 3a (0.7 g, 1.31 mmol) according to the general procedure 
described above Purification by column chromatography (hexane-EtOAc, 3:2) yielded a white 
solid (513 mg, 78%): m.p.= 85-86 °C; []D20 = +83 (c 0.96, CHCl3); 1H NMR (400 MHz , 
CDCl3):  = 3.68 (s, 2H), 4.01 (t, J = 8.0 Hz, 2H), 4.57 (t, J = 9.2 Hz, 2H), 4.82 (s, 2H), 5.01 
(t, J = 8.4 Hz, 2H), 7.08-7.27 (m, 14H), 7.34, 7.38 (2d, J = 6.4 Hz, 4H); 13C NMR (100 MHz, 
CDCl3):  = 42.9, 47.0, 69.3, 75.3, 123.9, 125.1, 126.1, 126.3, 126.6, 127.4, 128.6, 140.5, 
142.4, 142.5, 168.8; HRMS [ESI]: m/z calcd for C34H29N2O2: 497.2229 (M+H)+, found: 
497.2229. 
4.3.2. (11S,12S)-bis[(4’S)-phenyloxazoline]-9,10-dihydro-9,10-ethanoanthacene 4a' 
The product was synthesized from 3a' (0.50 g, 0.94 mmol) according to the general procedure 
described above. Purification by column chromatography (hexane-EtOAc, 3:2) yielded a 
white solid (300 mg, 68%): m.p.= 177 °C; []D20 = +31 (c 0.87, CHCl3); 1H NMR (400 MHz , 
CDCl3):  = 3.83 (s, 2H), 3.86 (t, J = 8.0 Hz, 2H), 4.50 (dd, J = 8.4, 10.0 Hz, 2H), 4.78 (s, 
2H), 4.92 (t, J = 8.8 Hz, 2H), 6.40 (d, J = 8.4 Hz, 4H), 7.05-7.18 (m, 12H), 7.23, 7.36 (2d, J = 
6.8 Hz, 4H); 13C NMR (100 MHz, CDCl3):  = 43.1, 46.5, 69.1, 75.9, 124.5, 124.9, 126.3, 
126.3, 126.4, 127.2, 128.4, 140.9, 142.0, 142.1, 169.2; HRMS [ESI]: m/z calcd for 
C34H29N2O2: 497.2229 (M+H)+, found: 497.2229 
4.3.3. (11S,12S)-Bis[(4’S)-isopropyloxazoline]-9,10-dihydro-9,10-ethanoanthacene 4b 
The product was synthesized from 3b (0.5 g, 1.0 mmol) according to the general procedure 
described above. Purification by column chromatography (hexane-EtOAc, 2:3) yielded a 
white solid (295 mg, 63%): m.p.= 67-69 °C; []D20 = -11 (c 0.52, CHCl3); 1H NMR (400 MHz 
, CDCl3):  = 0.65, 0.71 (2d, J = 6.8 Hz, 12H), 0.78, 0.92 (2 quintuplets, J = 7.2 Hz, 4H), 1.30 
( septuplet, J = 6.8 Hz, 2H), 3.46 (s, 2H), 3.69 (t, J = 7.2 Hz, 2H), 3.80 (quintuplet, J = 7.6 Hz, 
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2H), 4.13 (t, J = 8.0 Hz, 2H), 4.60 (s, 2H), 6.97-7.05 (m, 4H); 7.13, 7.27 (2d, J = 6.8 Hz, 4H); 
13C NMR (100 MHz, CDCl3):  = 22.6, 22.7, 24.9, 42.3, 45.8, 46.9, 64.0, 73.4, 124.0, 124.6, 
125.8, 126.1, 140.6, 141.8, 166.9; HRMS [ESI]: m/z calcd for C30H37N2O2: 457.2855, 
(M+H)+, found: 457.2857. 
4.3.4. (11S,12S)-Bis[(4’S)-tert-butyloxazoline]-9,10-dihydro-9,10-ethanoanthacene 4c 
The product was synthesized from 3c (0.5 g, 1.02 mmol) according to the general procedure 
described above. Purification by column chromatography (hexane-EtOAc, 3:1) yielded a 
white solid (404 mg, 86%): m.p.= 84-86 °C; []D20 = -19 (c 0.51 , CHCl3); 1H NMR (400 
MHz , CDCl3):  = 3.56 (s, 2H), 3.59 (t, J = 9.2 Hz, 2H), 3.86 (t, , J = 8.4 Hz, 2H), 4.07 (t, J = 
8.4 Hz, 2H), 4.60 (s, 2H), 6.92, 6.98 (2t, J = 7.2 Hz,4H), 7.10, 7.23 (2d, J = 7.2 Hz, 4H); 13C 
NMR (100 MHz, CDCl3):  = 25.6, 32.9, 43.0, 46.5, 69.1, 75.3, 123.7, 124.9, 125.97, 126.0, 
140.8, 142.3, 167.2; HRMS [ESI]: m/z calcd for C30H37N2O2: 457.2855 (M+H)+, 
found:457.2855. 
4.3.5. (11S,12S)-Bis(oxazoline)-9,10-dihydro-9,10-ethanoanthacene 4d 
The bis(hydroxyamide) 3d (250 mg, 0.66 mmol) in CH2Cl2 (5 ml) was treated with SOCl2 
(1.56 g, 13.1 mmol). After 15 min, the solution was heated at reflux for 3 h, then recooled to 
room temperature and washed sequentially with cold water (10 ml), 0.1 M K2CO3 (2 x 10 ml), 
and saturated aqueous NaCl (10ml). After drying over MgSO4 and evaporation, the crude 
bisamide dichloride was obtained as a white solid (175 mg, 93%): 1H NMR (400 MHz , 
CDCl3):  = 2.84 (s, 2H), 3.45 (m, 8H), 4.55 (s, 2H), 7.04-7.11 (m, 4H), 7.24, 7.29 (2d, J = 
6.4 Hz, 4H). HRMS [ESI]: m/z calcd for C22H22N2O2Cl2Na: 439.0956 (M+Na)+, found: 
439.0957. 
A mixture of the crude bisamide dichloride, 170mg (0.41 mmol), and Na0H (500 mg, 30 
mmol) in 50% aqueous MeOH (5 ml) was heated under reflux for 4 hours. After cooling, the 
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mixture was extracted with CH2CL2 and washed with saturated aqueous NaCl. Column 
chromatography on silica (EtOAc/MeOH, 9:1) yielded the ligand 4d as a white solid (102 mg, 
73%): m.p.= 95-98 °C;, 0.102g (73%). []D20 = +34 (c 1.23, CHCl3); 1H NMR (400 MHz , 
CDCl3):  = 3.38 (s, 2H), 3.44-3.64 (m, 4H), 4.06-4.16 (m, 4H), 4.62 (s, 2H), 6.99-7.05 (m, 
4H), 7.15, 7.25 (2d, J = 6.4 Hz, 4H); 13C NMR (100 MHz, CDCl3):  = 42,7, 46.9, 54.1, 67.8, 
123.8, 124.7, 126.0, 126.2, 140,4, 142.3, 168.4; HRMS [ESI]: m/z calcd for C22H21N2O2: 
345.1603 (M+H)+, found: 345.1611.  
4.3.6. (11R,12R)-Bis[(4’S)-phenyloxazoline]-9,10-dihydro-9,10-ethanoanthacene 4e 
The product was synthesized from 3e (0.5 g, 0.94 mmol) according to the general procedure 
described above. Purification by column chromatography (hexane-EtOAc, 3:2) yielded a 
white solid (440 mg, 68%): m.p.= 81-82 °C; []D20 = -82 (c 0.65, CHCl3); 1H NMR (400 MHz 
, CDCl3):  = 3.58 (s, 2H), 3.92 (t, J = 8.0 Hz, 2H), 4.48 (t, J = 8.4 Hz, 2H), 4.72 (s, 2H), 
54.90 (t, J = 8.0 Hz, 2H), 6.96-7.18 (m, 14H), 7.24, 7.28 (2d, J = 6.4 Hz, 4H); 13C NMR (100 
MHz, CDCl3):  = 43,1 46.5, 69.1, 75.9, 124.5, 124.9, 126.3, 126.3, 126.4, 127.2, 128.4, 
140.9, 142.0, 142.1, 169.2; HRMS [ESI]: m/z calcd for C34H29N2O2:497.2229 (M+H)+, found: 
497.2229. 
4.3.7. (11R,12R)-Bis[(4’R)-phenyloxazoline]-9,10-dihydro-9,10-ethanoanthacene 4e' 
The product was synthesized from 3e' (0.5 g, 0.94 mmol) according to the general procedure 
described above. Purification by column chromatography (hexane-EtOAc, 3:2) yielded a 
white solid (407 mg, 63%): m.p.= 178 °C; []D20 = -33 (c 0.87, CHCl3); 1H NMR (400 MHz , 
CDCl3):  = 3.83 (s, 2H), 3.87 (t, J = 8.0 Hz, 2H), 4.50 (dd, J = 8.4, 10.0 Hz, 2H), 4.78 (s, 
2H), 4.92 (t, J = 8.8 Hz, 2H), 6.41 (d, J = 7.2 Hz, 4H), 7.05-7.18 (m, 10H), 7.23, 7.36 (2d, J = 
6.8 Hz, 4H); 13C NMR (100 MHz, CDCl3):  = 43.1, 46.5, 69.1, 75.9, 124.5, 124.9, 126.3, 
 20 
126.3, 126.4, 127.2, 128.4, 140.9, 142.0, 142.1, 169.2; HRMS [ESI]: m/z calcd for 
C34H29N2O2: 497.2229 (M+H)+, found: 497.2229. 
4.3.8.(11S,12S+11R,12R)-Bis[(4’R)-phenyloxazoline]-9,10-dihydro-9,10-ethanoanthacene 
4f 
The product was synthesized from 3f (0.5 g, 0.94 mmol) according to the general procedure 
described above. Purification by column chromatography (hexane-EtOAc, 3:2) yielded a 
white solid (230 mg, 52%): m.p.= 91-95 °C; []D20 = +13 (c 10, CHCl3); 1H NMR (400 MHz , 
CDCl3):  = 3.58 (s, 2H), 3.83 (s, 2H), 3.87, 3.91 (2t, J = 8.0 Hz, 4H), 4.45-4.53 (m, 4H), 
4.72 (s, 2H), 4.78 (s, 2H), 4.87-4.95 (m, 4H), 6.41 (d, J = 6.0 Hz, 4H), 6.96-7.37 (m, 32H); 
13C NMR (100 MHz, CDCl3):  = 42.8, 43.1, 46.5, 47.0, 69.1, 69.2, 75.3, 75.9, 123.8, 124.5, 
124.8, 125.1, 126.1, 126.2, 126.3, 126.3, 126.4, 126.5, 127.2, 127.4, 128.4, 128.5, 140.4, 
140.9, 142.1, 142.3, 142.5, 168.8, 169.2; HRMS [ESI]: calcd for C34H29N2O2: 497.2229 
(M+H)+, found: 497.2229. 
4.3.9. Bis[(4’R)-phenyloxazoline]-9,10-dihydro-9,10-ethanoanthacene 7 
The product was synthesized from 6 (0.3 g, 0.56 mmol) according to the general procedure 
described above. Purification by column chromatography (hexane-EtOAc, 3:2) yielded a 
white solid (90 mg, 54%): m.p.= 60-62 °C; []D20 = +43, c 0.58, CHCl3); 1H NMR (400 MHz 
, CDCl3):  = 3.18 (d, J = 10.8 Hz, 1H), 3.35 (t, J = 8.4 Hz, 1H), 3.43 (d, J = 8.4 Hz, 1H), 3.54 
(dd, J = 2.0, 10.8 Hz, 1H), 4.04, 4.07 (2d, J = 8.4 Hz, 1H), 4.29, 4.31 (2d, J = 8.4 Hz, 1H), 
4.56 (d, J = 2Hz, 1H), 4.81 (s, 1H), 4.93 (t, J = 9.2 Hz, 2H), 5.03 (t, J = 9.4 Hz, 1H), 6.84-7.25 
(m, 17 H), 7.42-7.44 (m, 1H). 13C NMR (100 MHz, CDCl3):  = 41.6, 41.7, 46.5, 48.8, 69.0, 
69.1, 74.6, 74.8, 123.5, 124.0, 124.6, 125.7, 126.3, 126.4, 126.5, 126.7, 126.9, 127.1, 127.3, 
128.4, 128.6, 140.7, 141.2, 142.3, 142.4, 142.6, 143.7, 168.0, 168.2. HRMS [ESI]: m/z calcd 
for C34H29N2O2: 497.2229 (M+H)+, found: 497.2229. 
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4.4. General procedure for  asymmetric Diels-Alder reaction  
A mixture of Cu(II)(OTf)2 (5mol, 10 mol % ) and the ligand 4 (6 mol,) in dry CH2Cl2 (0.2 
ml) was stirred for 0.5 h at room temperature under argon. The dienophile (50 mol in 50 l 
CH2Cl2 ) and freshly distilled cyclopentadiene (150 mol) were then respectively added. The 
reaction was monitored by TLC and stopped after consumption of the starting substrate. The 
reaction mixture was purified on silica gel with hexane-ethyl acetate (3:1) to give a mixture of 
endo and exo isomers of cycloadducts 9. The yield was calculated on the basis of the isolated 
products. The endo/exo ratio was determined by 1H NMR analysis and confirmed by HPLC 
analysis. The enantiomeric excess of the cycloadduct was determined by chiral HPLC 
analysis: Daicel Chiralcel OD-H column, hexane-i-PrOH, 95:5, flow rate = 1 ml/min, 
detection: 220 m. The absolute configuration of the cycloadduct endo-9 product was 
assigned based upon the comparison of the sign of optical rotation with the literature values: 
(+) for (R)-9 and (-) for (S)-9. 
 
Supplementary data 
 Copies of 1H and 13C NMR spectra of bis(hydroxyamide) 3a, 3a’, 3b, 3c, 3d, 3e, 3e', 3f and 
6, copies of 1H and 13C NMR spectra of bis(oxazoline) 4a, 4a’, 4b, 4c, 4d, 4e, 4e', 4f and 7, 
HPLC chromatograms of selected Diels-alder reactions, X-ray crystallographic data of ligand 
4a. 
 
Legends 
 
Fig. 1. Structure of various chiral bis(oxazoline) ligands linked with a rigid backbone. 
Fig. 2. 1H NMR study of the epimerization of ligand 7 in CDCl3 
(A) After purification; Time: 1h 
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(B) Time: 24h
 
(C) Time: 48h 
Fig. 3. ORTEP drawing and atom labeling of ligand 4a 
Fig. 4. Cu(II)-complexes of the four diastereomeric ligands 4 and the correlation between 
structure of the ligand and configuration of the cycloadduct  
Scheme 1. Synthesis of different chiral bis(oxazoline) with a dihydroethanoanthracene 
backbone. 
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